Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion type Assertion NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_head.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_provenance.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion evidence source_evidence_literature NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_provenance.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion SIO_000772 19489767 NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_provenance.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion wasDerivedFrom befree-20150227 NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_provenance.
- NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_assertion wasGeneratedBy ECO_0000203 NP445117.RA3-S0NXbAFLxkTlD8Uoj1SEH3MbDR3LuQRDBr4yKMbbA130_provenance.